bibliographic resource 4786159 [br/4786159]
https://w3id.org/oc/corpus/br/4786159

is a

• document
• article

title

• 3LBA CheckMate 025: a randomized, open-label, phase III study of nivolumab (NIVO) versus everolimus (EVE) in advanced renal cell carcinoma (RCC)

publication date

• 2015-01-01

contributor

• https://w3id.org/oc/corpus/ar/18475050
• https://w3id.org/oc/corpus/ar/18475051
• https://w3id.org/oc/corpus/ar/18475052
• https://w3id.org/oc/corpus/ar/18475053
• https://w3id.org/oc/corpus/ar/18475054
• https://w3id.org/oc/corpus/ar/18475055
• https://w3id.org/oc/corpus/ar/18475056
• https://w3id.org/oc/corpus/ar/18475057
• https://w3id.org/oc/corpus/ar/18475058
• https://w3id.org/oc/corpus/ar/18475059
• https://w3id.org/oc/corpus/ar/18475060
• https://w3id.org/oc/corpus/ar/18475061
• https://w3id.org/oc/corpus/ar/18475062
• https://w3id.org/oc/corpus/ar/18475063
• https://w3id.org/oc/corpus/ar/18475064
• https://w3id.org/oc/corpus/ar/18475065
• https://w3id.org/oc/corpus/ar/18475066
• https://w3id.org/oc/corpus/ar/18475067
• https://w3id.org/oc/corpus/ar/18475068
• https://w3id.org/oc/corpus/ar/18475069
• https://w3id.org/oc/corpus/ar/18475070

format

• https://w3id.org/oc/corpus/re/2727160

identifier

• https://w3id.org/oc/corpus/id/9667922
• https://w3id.org/oc/corpus/id/9667923

part of

• https://w3id.org/oc/corpus/br/381